Schwannoma Clinical Trial
Official title:
Evolution of Cochleovestibular Schwannomas in the Internal Auditory Canal by Volume Measering With aTeslas MRI 3
NCT number | NCT04417868 |
Other study ID # | 7560 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | January 1, 2019 |
Est. completion date | July 2020 |
Investigators want to know the natural history of the vestibular schwannomas: increasing,
decreasing or stability, by monitoring more than 3 MRIs during a span of more than 2 years.
They will obtain 3 groups: the volume increasing schwannomas which will be the most important
group, the schwannomas that will be stable and a small group where the schwannomas will
decrease.
The secondary purpose is that the investigators want to know the threshold values: a minimum
volume under which we are sure that the schwannoma will not increase, a maximum value where
it will increase and if its evolution can be correlated to clinical or radiological criteria.
Status | Recruiting |
Enrollment | 140 |
Est. completion date | July 2020 |
Est. primary completion date | July 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age over 18 years - having a typical vestibular schwannoma diagnosis during the first MRI, having a minimum of 3 internal auditory canal MRIs on the same machine (Signa HDxt, General Electric, Strasbourg, France) ) at the Hôpitaux Universitaires de Strasbourg - patients consenting to participate Exclusion Criteria: - intra-labyrinthical extension - treatment before the 3 MRIs - no injection of gadolinium - atypical diagnosis |
Country | Name | City | State |
---|---|---|---|
France | Service Imagerie 1 | Srtrasbourg | Strasbourg |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Strasbourg, France |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Presence or absence of intra labyrinthine vestibular nerve tumor using T2 FIESTA | 1 hour after the realization of the MRI |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01347307 -
Stereotactic Body Radiotherapy for Spine Tumors
|
N/A | |
Completed |
NCT00603694 -
Hippocampal Radiation Exposure and Memory
|
N/A | |
Recruiting |
NCT04712214 -
Use of Non-invasive Optical Analysis in Neurosurgery
|
N/A | |
Recruiting |
NCT05139277 -
Evaluation of the CONVIVO System
|
N/A | |
Completed |
NCT01951365 -
Assessment of Volumetric Growth Rates of Spinal Intradural Extramedullary Schwannoma
|
N/A | |
Recruiting |
NCT05576103 -
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
|
||
Recruiting |
NCT06421805 -
Establishing Prospective Mediastinal Tumor Database of PUMCH
|
||
Recruiting |
NCT05254197 -
SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)
|
||
Recruiting |
NCT03580850 -
MRI Scan and Intra-labyrinthine Schwannoma
|
||
Recruiting |
NCT04278118 -
Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
|
N/A |